Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

254 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
High dose oral and intravenous rifampicin for improved survival from adult tuberculous meningitis: a phase II open-label randomised controlled trial (the RifT study).
Cresswell FV, Ssebambulidde K, Grint D, Te Brake L, Musabire A, Atherton RR, Tugume L, Muzoora C, Lukande R, Lamorde M, Aarnoutse R, Meya D, Boulware DR, Elliott AM. Cresswell FV, et al. Among authors: aarnoutse r. Wellcome Open Res. 2018 Jul 10;3:83. doi: 10.12688/wellcomeopenres.14691.1. eCollection 2018. Wellcome Open Res. 2018. PMID: 30175245 Free PMC article.
The Potential for Treatment Shortening With Higher Rifampicin Doses: Relating Drug Exposure to Treatment Response in Patients With Pulmonary Tuberculosis.
Svensson EM, Svensson RJ, Te Brake LHM, Boeree MJ, Heinrich N, Konsten S, Churchyard G, Dawson R, Diacon AH, Kibiki GS, Minja LT, Ntingiya NE, Sanne I, Gillespie SH, Hoelscher M, Phillips PPJ, Simonsson USH, Aarnoutse R. Svensson EM, et al. Among authors: aarnoutse r. Clin Infect Dis. 2018 Jun 18;67(1):34-41. doi: 10.1093/cid/ciy026. Clin Infect Dis. 2018. PMID: 29917079 Free PMC article.
Intensified antibiotic treatment of tuberculosis meningitis.
Cresswell FV, Te Brake L, Atherton R, Ruslami R, Dooley KE, Aarnoutse R, Van Crevel R. Cresswell FV, et al. Among authors: aarnoutse r. Expert Rev Clin Pharmacol. 2019 Mar;12(3):267-288. doi: 10.1080/17512433.2019.1552831. Epub 2019 Feb 12. Expert Rev Clin Pharmacol. 2019. PMID: 30474434 Review.
High-dose rifampicin in tuberculosis: Experiences from a Dutch tuberculosis centre.
Seijger C, Hoefsloot W, Bergsma-de Guchteneire I, Te Brake L, van Ingen J, Kuipers S, van Crevel R, Aarnoutse R, Boeree M, Magis-Escurra C. Seijger C, et al. Among authors: aarnoutse r. PLoS One. 2019 Mar 14;14(3):e0213718. doi: 10.1371/journal.pone.0213718. eCollection 2019. PLoS One. 2019. PMID: 30870476 Free PMC article.
Tuberculous meningitis: new tools and new approaches required.
Seddon JA, Thwaites GE; Tuberculous Meningitis International Research Consortium. Seddon JA, et al. Wellcome Open Res. 2019 Nov 19;4:181. doi: 10.12688/wellcomeopenres.15591.1. eCollection 2019. Wellcome Open Res. 2019. PMID: 31803849 Free PMC article.
Management of intracranial tuberculous mass lesions: how long should we treat for?
Marais S, Van Toorn R, Chow FC, Manesh A, Siddiqi OK, Figaji A, Schoeman JF, Meintjes G; Tuberculous Meningitis International Research Consortium. Marais S, et al. Wellcome Open Res. 2019 Oct 31;4:158. doi: 10.12688/wellcomeopenres.15501.2. eCollection 2019. Wellcome Open Res. 2019. PMID: 32047859 Free PMC article.
Pharmacokinetics, SAfety/tolerability, and EFficacy of high-dose RIFampicin in tuberculosis-HIV co-infected patients on efavirenz- or dolutegravir-based antiretroviral therapy: study protocol for an open-label, phase II clinical trial (SAEFRIF).
Nabisere R, Musaazi J, Denti P, Aber F, Lamorde M, Dooley KE, Aarnoutse R, Sloan DJ, Sekaggya-Wiltshire C. Nabisere R, et al. Among authors: aarnoutse r. Trials. 2020 Feb 13;21(1):181. doi: 10.1186/s13063-020-4132-7. Trials. 2020. PMID: 32054536 Free PMC article.
254 results